SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

Lantheus Welcomes CMS CY27 Final Rule on Diagnostic Radiopharmaceuticals

Lantheus said it welcomes the CMS CY27 final rule, which it describes as advancing access to diagnostic radiopharmaceuticals.

LNTH

Related stories